Study: GLP-1 drugs Linked to 42% Lower Mental Illness Risk
Are GLP-1 drugs a dangerous lifetime dependency or a revolutionary breakthrough for physical and mental health?
Image credit: Peter Dazeley/Getty Images
The Spin
Narrative A
Semaglutide isn't just a weight-loss drug — it's linked to a 42% lower risk of worsening mental health, a 44% drop in worsening depression and a 47% reduction in substance use disorder. For diabetic patients already facing two to three times higher depression rates, that's a game-changer. The mental health case for GLP-1 drugs is now impossible to dismiss.
Narrative B
GLP-1 drugs might show promising numbers, but stopping them triggers "metabolic whiplash" — undoing all cardiovascular benefits in half the time it took to build them. These aren't temporary fixes; they're lifetime dependencies that erode self-regulation and personal discipline. Real health has always required effort, and no pill changes that fundamental truth.